Bronchoscopic lung volume reduction with valves: What should the internist know?
| Autor: | Thomas R. Gildea, Joseph Cicenia, Khaled Alshabani, Michael Machuzak, Umur Hatipoğlu |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Lung volume reduction
medicine.medical_specialty Lung business.industry Patient Selection Hyperinflation General Medicine respiratory system Bronchoscopic lung volume reduction respiratory tract diseases 03 medical and health sciences Treatment Outcome 0302 clinical medicine medicine.anatomical_structure Pulmonary Emphysema medicine Humans 030212 general & internal medicine Radiology Pneumonectomy business Mucus clearance |
| Zdroj: | Cleveland Clinic Journal of Medicine. 87:278-287 |
| ISSN: | 1939-2869 0891-1150 |
| Popis: | Traditional therapies for emphysema such as bronchodilators and anti-inflammatory drugs have limited value due to permanent structural changes in the emphysematous lung that result in hyperinflation. Surgical lung volume reduction partially corrects hyperinflation by removing emphysematous lung and is an option in selected patients, but it carries a risk of morbidity and death. Valve therapy is a less-invasive option that involves bronchoscopic implantation of 1-way valves in emphysematous lung segments to allow air flow and mucus clearance in the direction of central airways. The authors review the rationale, evidence, and applications of valve therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|